Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.
about
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical applicationHepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsThe role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a reviewDetection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent.Hepatic arterial phase on gadoxetic acid-enhanced liver MR imaging: a randomized comparison of 0.5 mL/s and 1 mL/s injection rates.Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticlesGd-EOB-DTPA-enhanced MR guidance in thermal ablation of liver malignancies.Hepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications.Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians.Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography.Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe3O4 magnetic nanoparticles.Albumin-based nanoparticles loaded with hydrophobic gadolinium chelates as T1-T2 dual-mode contrast agents for accurate liver tumor imaging.Three-dimensional images of liver tumours reconstructed by Gd-EOB-DTPA-enhanced MRI.Inter-observer agreement on the assessment of relative liver lesion signal intensity on hepatobiliary phase imaging with gadoxetate (Gd-EOB-DTPA)A synergistically enhanced T(1) -T(2) dual-modal contrast agent.Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging.MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.Diffusion-weighted MRI of the abdomen: current value in clinical routine.Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research.Evaluation of hepatic focal lesions using diffusion-weighted MR imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived parameters.Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases?P4 radiology of hepatobiliary diseases with gadoxetic acid-enhanced MRI as a biomarker.Navigated three-dimensional T1-weighted gradient-echo sequence for gadoxetic acid liver magnetic resonance imaging in patients with limited breath-holding capacity.Liver-specific magnetic resonance contrast medium in the evaluation of chronic liver disease.The risk factors and diagnosis of cholangiocarcinoma.Recommendations on the use of MRI in PSC-A position statement from the International PSC study group.Percutaneous biopsy in the abdomen and pelvis: a step-by-step approach.Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastasis: the radiologist's perspective.Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?Respiratory motion artifacts during arterial phase imaging with gadoxetic acid: Can the injection protocol minimize this drawback?Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastasesMagnetic resonance of the liver with hepato-specific contrast: initial clinical experience in Brazil.Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen.Comparison of MRI with liver-specific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: a meta-analysis of 15 direct comparative studies.Functional evaluation of cystic duct patency with Gd-EOB-DTPA MR imaging: an alternative to hepatobiliary scintigraphy for diagnosis of acute cholecystitis?Differentiating primary hepatic angiosarcomas from hemangiomatosis and epithelioid hemangioendotheliomas using gadoxetic acid-enhanced and diffusion-weighted MR imaging.
P2860
Q24613744-50F83065-11DE-429C-B2D6-370DA811070AQ26783881-ACE941CB-7692-4E61-B872-1151BED41CCFQ26828543-2F6A6ED0-8629-4D2A-A1DA-55B7590CCE0DQ34064365-EEEC46D5-205B-4C5E-8394-D4F2CE6C46ACQ34219619-0FFEF190-60B0-4B6D-9198-ED0725837FACQ34391776-63945EDC-1C3B-4E14-B2FD-1D8EDEC4A9B4Q34444404-E67362A3-5219-4972-8950-552DF944664FQ34775900-F5B698FD-F190-400E-B35B-1D69B3485825Q35124054-F392F531-7966-4FEA-BBC2-6A4ADC6AF9D9Q35207733-0648E58C-2CB1-4E90-AC6C-7278F86DC179Q35775870-72C20A54-AF01-4CD5-8C5F-EB2A978C0247Q36056202-95483C14-C549-4406-AD5F-1B7963077C0FQ36083221-46EAA967-3CD9-4A96-922D-CBF1CDA6B581Q36314337-1EF326EA-A43B-4AC2-BFEB-7501F7B60A18Q36325906-735961E4-BF19-4168-B7EE-2FE7973D6B2BQ36542919-86FB6839-046D-423C-82BB-EBB59539B8D0Q36790059-5D049E2D-D586-4147-BAE5-61CF10377CE0Q36854172-8763EAA1-17CB-4A26-A90E-722C18D77075Q37329995-11161931-643C-4BED-94E5-5BBB598FB495Q37962879-1A09E9D2-55C1-4169-94CE-58205F0D7F41Q38068826-B96DDC07-6D5E-4F28-BFB0-4CBB0952C417Q38102018-C2D1F4E0-4183-4707-8589-F1349852B31DQ38103204-5149899F-9A33-4098-A8BB-C95F92976D91Q38117581-F19B0F1C-DF84-4785-AD17-EB95D588528FQ38132368-934ED70A-CD05-4D89-ACB4-8DDFD80D49C4Q38177850-C95B42C5-8122-4534-A069-ED2E428ADF5FQ38238929-703D31FF-9129-4605-9132-C90E0C2B946CQ38543942-309914C5-79C7-4CA0-B941-870742F762F2Q38552233-682427E8-1040-4065-80C6-FCFC022501B1Q38677506-0C59F8E1-7EDA-4E3A-A5D6-BE9367F016A5Q38736378-7795DBD3-9A4A-43B1-B797-9D3FAD2D985FQ38845323-5AAA8C41-8A5E-4094-9501-1694152A678DQ39013059-68813B4B-0F02-4F58-9A2B-03FE1573664DQ39127947-9A70F3C0-599B-4E22-966C-91230A3ACE56Q41455041-4CE01C5C-2A56-487D-AA80-FF8CE0B3E537Q43576446-A3A238CA-4C25-493E-9426-17CB1786C7ECQ46210542-19E08130-5497-47FA-845E-38A325FD4CF3Q47821895-305E9B79-DAD5-49C2-AF91-6FC6E7602B78Q50157731-2A7D50F6-0F63-4118-A269-85E201E5A771Q50210190-B6859B23-D304-47AC-8AB0-B92EFD5B94D4
P2860
Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical value of MRI liver-sp ...... gnosis of focal liver lesions.
@en
Clinical value of MRI liver-sp ...... gnosis of focal liver lesions.
@nl
type
label
Clinical value of MRI liver-sp ...... gnosis of focal liver lesions.
@en
Clinical value of MRI liver-sp ...... gnosis of focal liver lesions.
@nl
prefLabel
Clinical value of MRI liver-sp ...... gnosis of focal liver lesions.
@en
Clinical value of MRI liver-sp ...... gnosis of focal liver lesions.
@nl
P2093
P2860
P1433
P1476
Clinical value of MRI liver-sp ...... gnosis of focal liver lesions.
@en
P2093
Ahmed Ba-Ssalamah
Christian Herold
Martin Uffmann
Nina Bastati
Sanjai Saini
Wolfgang Schima
P2860
P2888
P304
P356
10.1007/S00330-008-1172-X
P407
P577
2008-09-23T00:00:00Z